Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Vitamin D pathway gene variants and prostate cancer risk.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jun 2009

Holt Sarah K, Kwon Erika M, Peters Ulrike, Ostrander Elaine A, Stanford Janet L

Abstract excerpt

Vitamin D has antiproliferative, antiangiogenic, and apoptotic properties. There is some evidence supporting an association between vitamin D-related gene variants and prostate cancer risk. We report results from this population-based case-control study of genes encoding for the vitamin D receptor (VDR), the vitamin D activating enzyme 1-alpha-hydroxylase (CYP27B1), and deactivating enzyme 24-hydroxylase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Cholestanetriol 26-Monooxygenase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Prostatic Neoplasms

Share to Receptors, Calcitriol

Share to Risk Factors

Share to Steroid Hydroxylases

Share to Vitamin D

Share to Vitamin D3 24-Hydroxylase

Source

Open in PubMed Open full text

Identifiers

PMID: 19454612
DOI: 10.1158/1055-9965.EPI-09-0113
PMCID: PMC2743676

Genes

VDR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Vitamin D pathway gene variants and prostate cancer risk.PMID 19454612Read ↗

Comprehensive association analysis of the vitamin D pathway genes, VDR, CYP27B1, and CYP24A1, in prostate cancer.Semantic proximity Read ↗

Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study.Semantic proximity Read ↗

Vitamin D pathway gene variants and prostate cancer prognosis.Semantic proximity Read ↗

Genetic variation in the vitamin d pathway in relation to risk of prostate cancer--results from the breast and prostate cancer cohort consortium.Semantic proximity Read ↗

Associations of vitamin D pathway genes with circulating 25-hydroxyvitamin-D, 1,25-dihydroxyvitamin-D, and prostate cancer: a nested case-control study.Semantic proximity Read ↗

Circulating vitamin D, vitamin D-related genetic variation, and risk of fatal prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Semantic proximity Read ↗

Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.Semantic proximity Read ↗

Vitamin D Pathway and Other Related Polymorphisms and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial.Semantic proximity Read ↗

Genetic variants in the vitamin d receptor are associated with advanced prostate cancer at diagnosis: findings from the prostate testing for cancer and treatment study and a systematic review.Semantic proximity Read ↗

Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population.Semantic proximity Read ↗

Gene polymorphisms and prostate cancer: the evidence.Semantic proximity Read ↗

Vitamin D receptor polymorphisms and prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.